Figure 1. Chiral diarylether heptanoids lacking stereocenters.
Scheme 1. Racemic Synthesis of Chiral Diarylether Heptanoids
Lacking Stereocenters
of this natural product family have broad biological
activities including leishmanicidal,10 anti-inflammation,11
and anticancer activities.12 The DAEHs have attracted
interest from synthetic chemists.12b,13
Our interest in the DAEHs arises from their chiral
properties.14 Recently, we showed that of the 16 DAEHs
Figure 2. Evaluation of binapthol-type ligands in the Ullmann
coupling of 7. Yield based on recovered starting material.
Isolated yield (average of three trials).
a
b
(9) (a) Zhu, J.; Islas-Gonzalez, G.; Bois-Choussy, M. Org. Prep.
Proc. Int. 2000, 32, 505–546. (b) Claeson, P.; Tuchinda, P.; Reutrakul, V.
J. Indian Chem. Soc. 1994, 71, 509–521.
(10) Takahashi, M.; Fuchino, H.; Sekita, S.; Satake, M. Phytother.
Res. 2004, 18, 573–578.
(11) Singh, S. B.; Jayasuriya, H.; Zink, D. L.; Polishook, J. D.;
Dombrowski, A. W.; Zweerink, H. Tetrahedron Lett. 2004, 45, 7605–
7608.
(12) (a) Ishida, J.; Kozuka, M.; Tokuda, H.; Nishino, H.; Nagumo,
S.; Lee, K.-H.; Nagai, M. Bioorg. Med. Chem. 2002, 10, 3361–3365. (b)
Bryant, V. C.; Kumar, G. D. K.; Nyong, A. M.; Natarajan, A. Bioorg.
Med. Chem. Lett. 2012, 22, 245–248. (c) Jin, W. Y.; Cai, X. F.; Na, M. K.;
Lee, J. J.; Bae, K. H. Biol. Pharm. Bull. 2007, 30, 810–813. (d) Akihisa,
T.; Takeda, A.; Akazawa, H.; Kikuchi, T.; Yokokawa, S.; Ukiya, M.;
Fukatsu, M.; Watanabe, K. Chem. Biodivers. 2012, 9, 1475–1489.
that do not possess a stereocenter, 4 DAEHs are chiral:
(ꢀ)-myricatomentogenin,15 (ꢀ)-jugcathanin,16 (þ)-galeon,15,17
and (þ)-pterocarine.18 These chiral DAEHs all possess the
same pR19 absolute configuration (Figure 1).14a Our synthe-
ses of the racemic DAEHs involves an intramolecular
Ullmann ether coupling of bromophenols 1, 2, and 3 to
(15) Morihara, M.; Sakurai, N.; Inoue, T.; Kawai, K.-i.; Nagai, M.
Chem. Pharm Bull. 1997, 45, 820–823.
€
ꢀ
ꢀ
ꢀ
(13) (a) Keseru, G. M.; Dienes, Z.; Nogradi, M.; Kajtar-Peredy, M.
(16) (a) Li, Y.-X.; Ruan, H.-L.; Zhou, X.-F.; Zhang, Y.-H.; Pi, H.-F.;
Wu, J.-Z. Chem. Res. Chin. Univ. 2008, 24, 427–429. (b) Liu, J.-X.; Di,
D.-L.; Wei, X.-N.; Han, Y. Planta Med. 2008, 74, 754–759.
(17) Malterud, K. E.; Anthonsen, T.; Hjortas, J. Tetrahedron Lett.
1976, 17, 3069–3072.
(18) Liu, H. B.; Cui, C. B.; Cai, B.; Gu, Q. Q.; Zhang, D. Y.; Zhao,
Q. C.; Guan, H. S. Chin. Chem. Lett. 2005, 16, 215–218.
(19) For review of the stereochemical descriptors pR and pS, see:
Eliel, E. L.; Wilen, S. H.; Mander, L. N. Stereochemistry of Organic
Compounds: Wiley-Interscience: New York, 1994; pp 1121ꢀ1122.
J. Org. Chem. 1993, 58, 6725–6728. (b) Kumar, G. D. K.; Natarajan, A.
Tetrahedron Lett. 2008, 49, 2103–2105. (c) Vermes, B.; Keseru, G. M.;
^
ꢀ
ꢀ
ꢀ
ꢀ
Mezey-Vandor, G.; Nogradi, M.; Toth, G. Tetrahedron 1993, 49, 4893–
4900. (d) Islas Gonzalez, G.; Zhu, J. J. Org. Chem. 1999, 64, 914–924. (e)
Jeong, B.-S.; Wang, Q.; Son, J.-K.; Jahng, Y. Eur. J. Org. Chem. 2007,
1338–1344.
(14) (a) Salih, M. Q.; Beaudry, C. M. Org. Lett. 2012, 14, 4026–4029.
(b) Zhu, Z.-Q.; Salih, M. Q.; Fynn, E.; Bain, A. D.; Beaudry, C. M.
J. Org. Chem. 2013, 78, 2881–2896. (c) Zhu, Z.-Q.; Beaudry, C. M.
J. Org. Chem. 2013, 78, 3336–3341.
B
Org. Lett., Vol. XX, No. XX, XXXX